Carysil Limited presents its investor strategy focusing on sustainable growth and capital efficiency.
Company reports FY25 revenue of ₹816 Cr and EBITDA of ₹147 Cr, achieving a 5-year revenue CAGR of 27.4%.
Announces planned ₹300 Cr capital expenditure to expand manufacturing capacity and accelerate FY30 growth ambitions.
Highlights capacity expansion from 3 to 6 plants and significant increases in production volumes across all product lines since FY20.